Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • April 23, 2021; March 2019; March 2017; May 2016; Feb. 2016; July 2014; Oct. 2012; Oct. 2010; Jan. 2008; March 2003; March 2002; March 2001; March 2000; May 1999; Feb. 1999; Feb. 1998; March 1997; Aug. 1995
  • Initially developed
    • Jan. 1995